Venture

Nicolas Tricaud

Technologies

Therapeutic

Indication

Autoimmune & Inflammation

Central Nervous System Disorders

Clinical Research

Clinical Trials

Metabolic Disease

Neurodegenerative Disease

Obesity

Orphan Diseases

Additional Information

Women Founded

Nervosave is an early-stage biotech company incorporated in Montpellier, France & New York, USA, with a focus on the prevention and cure of myelin-related disorders.

 

Nervosave Therapeutics Team:

Cathy Beaumard

Nicolas Tricaud